HEPATIC DISORDERS
Cholestatic jaundice and hepatitis may occur very rarely,
up to two months after treatment with flucloxacillin has
been stopped. Administration for more than 2 weeks and
increasing age are risk factors. Manufacturer advises:
. flucloxacillin should not be used in patients with a
history of hepatic dysfunction associated with
flucloxacillin;
. flucloxacillin should be used with caution in patients
with hepatic impairment;
. careful enquiry should be made about hypersensitivity
reactions to beta-lactam antibacterials.
PDF page 604
→Appendix 1: penicillins
PDF page 604
Arthralgia. bronchospasm. coma.
dyspnoea. electrolyte imbalance. eosinophilia. erythema
nodosum. gastrointestinal disorder. hallucination.
Jarisch-Herxheimer reaction. myalgia. purpura non-
thrombocytopenic. vasculitis
PDF page 604
Not known to be harmful.
PDF page 604
Trace amount in milk, but appropriate to
use.
PDF page 604
Manufacturer advises caution.
PDF page 604
Dose adjustments ▶In adults Reduce dose if eGFR less than
10 mL/minute/1.73 m2; rashes more common.
▶In children Reduce dose or frequency if estimated
glomerular filtration rate less than 10 mL/minute/1.73 m2;
rashes more common.
l EFFECT ON LABORATORY TESTS False-positive urinary
glucose (if tested for reducing substances).
PDF page 604